Haematologica (Dec 2022)

Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma

  • Yang Liu,
  • Fangfang Yan,
  • Vivian Changying Jiang,
  • Yijing Li,
  • Yuxuan Che,
  • Joseph McIntosh,
  • Alexa Jordan,
  • Ian Hou,
  • Lei Nie,
  • Jingling Jin,
  • Wei Wang,
  • Heng-Huan Lee,
  • Yixin Yao,
  • Michael Wang

DOI
https://doi.org/10.3324/haematol.2022.282031
Journal volume & issue
Vol. 108, no. 5

Abstract

Read online

No abstracts available.